Worldwide Molecular Diagnostics Markets to 2024 - A 2019 Study Featuring 137 Key & Niche Market Player Profiles - ResearchAndMarkets.com

January 16, 2019

DUBLIN--(BUSINESS WIRE)--Jan 16, 2019--The “Molecular Diagnostics - Market Analysis, Trends, and Forecasts” report has been added to ResearchAndMarkets.com’s offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets.

This report analyzes the worldwide markets in US$ Thousand by the following Applications:

Infectious Disease Testing Blood Screening Cancer Screening Other Applications

The report profiles 137 companies including many key and niche players such as:

Abbott Laboratories (USA) Abbott Molecular (USA) Becton, Dickinson and Company (USA) bioMrieux SA (France) Cepheid (USA) F. Hoffmann-La Roche Ltd. (Switzerland) Grifols International, S.A. (Spain) Hologic, Inc. (USA) QIAGEN N.V. (The Netherlands) QuestDiagnostics, Inc. (USA) Siemens Healthcare GmBH (Germany) Tecan Group Ltd. (Switzerland) The ELITechGroup (France) Thermo Fisher Scientific (USA)

Topics Covered

1. Global Market Overview

2. Growth Drivers and Market Trends

Aging Population Drives Molecular Diagnostics Market Global Aging Population Statistics Technological Innovations Set to Drive the Market The Role of Molecular Diagnostics in Personalized Medicine Select Key Approved Personalized Medicines and Associated Biomarkers by Therapeutic Area Companion Diagnostics Drive Personalized Medicine List of FDA Approved Complementary and Companion Diagnostic Assays Biomarkers as Companion Diagnostics Rise in Healthcare Spending in Developing Nations Bode Well for Market Growth Proteomics Technologies: Growing in Significance New Developments in Proteomics Technologies New Applications Hold Promising Potential Molecular Diagnostics for Lymphoid Malignancies Next-Generation Sequencing (NGS) Technologies Keep Up the Momentum Select NGS Platforms Available in the Market Rising Emphasis on Lab Automation to Augur Well for Market Growth List of Fully Automated and Rapid Molecular Diagnostics Molecular Diagnostics and Intellectual Property

3. Application Areas of Molecular Diagnostics

4. Competition in the Molecular Diagnostics Market

5. Product & Technology Overview

6. Product Approvals/Introductions

7. Recent Industry Activity

8. Focus on Select Global Players

9. Global Market Perspective

Total Companies Profiled: 137 (including Divisions/Subsidiaries 158)

The United States (95) Canada (3) Japan (1) Europe (47) France (5)Germany (11)The United Kingdom (9)Italy (2)Spain (1)Rest of Europe (19) Asia-Pacific (Excluding Japan) (11) Middle East (1)

For more information about this report visit https://www.researchandmarkets.com/research/sz8c9g/worldwide?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190116005306/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Molecular Diagnostics



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 01/16/2019 05:07 AM/DISC: 01/16/2019 05:07 AM


Update hourly